Who owns Alzamend Neuro Inc?
Institutional ownership of ALZN from SEC Form 13F filings across 9 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
9
13F holders
$1.7M
value, 2026 filers
41.7%
of shares outstanding (1.4M sh)
2
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of ALZN's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | KMT WEALTH MANAGEMENT, LLCNEW | 1.3M | $1.6M | 1.3% | 39.8% | new |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | 26,371 | $31,644 | 0.0% | 0.8% | -42.3% |
| 3 | VANGUARD FIDUCIARY TRUST CO | 21,020 | $25,224 | 0.0% | 0.6% | 0.0% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 7,556 | $9,067 | 0.0% | 0.2% | -14.1% |
| 5 | Tower Research Capital LLC (TRC) | 3,517 | $4,220 | 0.0% | 0.1% | -43.1% |
| 6 | UBS Group AG | 2,352 | $2,822 | 0.0% | 0.1% | -47.8% |
| 7 | BlackRock, Inc. | 437 | $524 | 0.0% | 0% | 0.0% |
| 8 | IFG Advisory, LLCNEW | 22 | $26 | 0.0% | 0% | new |
| 9 | SBI Securities Co., Ltd. | 22 | $26 | 0.0% | 0% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.